×
Cooper Receivables 2010-2024 | COO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cooper receivables for the quarter ending October 31, 2024 were
$0.717B
, a
17.6% increase
year-over-year.
Cooper receivables for 2024 were
$0.717B
, a
17.6% increase
from 2023.
Cooper receivables for 2023 were
$0.61B
, a
9.3% increase
from 2022.
Cooper receivables for 2022 were
$0.558B
, a
8.25% increase
from 2021.
View More
Cooper Receivables 2010-2024 | COO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cooper receivables for 2024 were
$0.717B
, a
17.6% increase
from 2023.
Cooper receivables for 2023 were
$0.61B
, a
9.3% increase
from 2022.
Cooper receivables for 2022 were
$0.558B
, a
8.25% increase
from 2021.
Related Stocks
Company Name
Market
Cap
McKesson (MCK)
$75.2B
Becton Dickinson (BDX)
$68.8B
Cardinal Health (CAH)
$30.6B
West Pharmaceutical Services (WST)
$24.4B
Labcorp (LH)
$20B
Align Technology (ALGN)
$16.7B
Henry Schein (HSIC)
$9.1B
Merit Medical Systems (MMSI)
$6B
DENTSPLY SIRONA (XRAY)
$3.7B
Patterson (PDCO)
$2.7B
CONMED (CNMD)
$2.1B
STAAR Surgical (STAA)
$1.1B
Lifevantage (LFVN)
$317M
Pro-Dex (PDEX)
$145M